Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31685849 | 0.87 | ADORA1 (0.45) | ADORA1 | |
| SCHEMBL31685365 | 0.86 | ALDH1A1 (0.47) | — | |
| SCHEMBL31685629 | 0.84 | ATIC (0.52) | ADORA1 | |
| SCHEMBL31685368 | 0.83 | ADORA1 (0.53) | ADORA1 | |
| SCHEMBL31685526 | 0.83 | MEN1 (0.41) | ADORA1 | |
| SCHEMBL31685366 | 0.82 | ADORA1 (0.39) | ADORA1CYP2C19HIF1A | |
| SCHEMBL31685453 | 0.81 | P2RY1 (0.39) | ADORA1 | |
| SCHEMBL31685460 | 0.80 | DNPH1 (0.42) | ADORA1CYP2C19HIF1A | |
| SCHEMBL31685296 | 0.79 | ADORA1 (0.51) | ADORA1 | |
| SCHEMBL31685584 | 0.77 | ADORA1 (0.53) | ADORA1CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | ADORA1 935/4885CYP2C19 4442/4885HIF1A 2471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.